CUROGEN is participating in two healthcare investor conferences this September, having been invited to both events.
 

The company is attending the Wells Fargo 21st Annual Healthcare Conference in Boston,MA on September 10, followed by the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY on September 14.
 

At the Wells Fargo conference, in addition to partnering meetings with global investors and leading pharmaceutical companies, CUROGEN will have the opportunity to present the company and its pipeline in a dedicated 35-minute session.
 

CEO Chang-Woo Lee and Global Business Division Leader Angela Jihyun Lee are representing CUROGEN at both conferences, where the company will introduce its pipeline to major investors and industry leaders and hold further discussions on potential collaboration and partnership opportunities.
 

These conferences mark a meaningful milestone for CUROGEN, offering the opportunity to deepen relationships with the global investment community and global pharmaceutical industry and take a further step toward the company's global expansion.